• 9930 Citations
  • 49 h-Index
1976 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Lee S. Schwartzberg is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 8 Similar Profiles
Drug Therapy Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
Nausea Medicine & Life Sciences
Vomiting Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
docetaxel Medicine & Life Sciences
Antiemetics Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1976 2019

1 Citation (Scopus)
Open Access
Nausea
Vomiting
Drug Therapy
aprepitant
Anthracyclines

Health-related quality of life in patients receiving first-line eribulin mesylate with or without trastuzumab for locally recurrent or metastatic breast cancer

Schwartzberg, L., McIntyre, K., Wilks, S., Puhalla, S., O'Shaughnessy, J., Berrak, E., He, Y. & Vahdat, L., Jun 13 2019, In : BMC Cancer. 19, 1, 578.

Research output: Contribution to journalArticle

Open Access
eribulin
Quality of Life
Breast Neoplasms
Constipation
Dyspnea

Open-label Clinical Trial of Niraparib Combined with Pembrolizumab for Treatment of Advanced or Metastatic Triple-Negative Breast Cancer

Vinayak, S., Tolaney, S. M., Schwartzberg, L., Mita, M., McCann, G., Tan, A. R., Wahner-Hendrickson, A. E., Forero, A., Anders, C., Wulf, G. M., Dillon, P., Lynce, F., Zarwan, C., Erban, J. K., Zhou, Y., Buerstatte, N., Graham, J. R., Arora, S., Dezube, B. J. & Telli, M. L., Aug 1 2019, In : JAMA Oncology. 5, 8, p. 1132-1140 9 p.

Research output: Contribution to journalArticle

Triple Negative Breast Neoplasms
Clinical Trials
Therapeutics
Disease-Free Survival
Safety

Prediction of chemotherapy benefit by EndoPredict in patients with breast cancer who received adjuvant endocrine therapy plus chemotherapy or endocrine therapy alone

Sestak, I., Martín, M., Dubsky, P., Kronenwett, R., Rojo, F., Cuzick, J., Filipits, M., Ruiz, A., Gradishar, W., Soliman, H., Schwartzberg, L., Buus, R., Hlauschek, D., Rodríguez-Lescure, A. & Gnant, M., Jul 30 2019, In : Breast Cancer Research and Treatment. 176, 2, p. 377-386 10 p.

Research output: Contribution to journalArticle

Open Access
Breast Neoplasms
Drug Therapy
Therapeutics
Adjuvant Chemotherapy
Proportional Hazards Models

Preventing chemotherapy-induced nausea and vomiting with netupitant/palonosetron, the first fixed combination antiemetic: Current and future perspective

Aapro, M., Zhang, L., Yennu, S., Leblanc, T. W. & Schwartzberg, L., Apr 1 2019, In : Future Oncology. 15, 10, p. 1067-1084 18 p.

Research output: Contribution to journalArticle

Open Access
Antiemetics
Nausea
Vomiting
Drug Therapy
Guidelines